Metanova Labs revolutionizes drug discovery by leveraging decentralized AI to screen billions of molecules efficiently.
Compound libraries are curated collections of chemical molecules used in drug discovery. A range of screening collections, ...
Persistent Launches AI-Powered Generative Molecules and Virtual Screening Solution Powered by NVIDIA
Persistent Systems (BSE: 533179) (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today ...
AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...
Deep Origin, the computational drug discovery company replacing guesswork with prediction in small molecule drug development, today announced the promotion of Natalie Ma, PhD, to Chief Business ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
This article and associated images are based on a poster originally authored by Lin Chen, Vincent Blay, Pedro J. Ballester and Douglas R. Houston and presented at ELRIG Drug Discovery 2025 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results